 |
인쇄하기
취소
|
Insurance Coverage for MSD Korea's Singulair Now Expanded
Effective February 1st, the National Health Insurance (NHI) eligible coverage for MSD Korea's Singulair, a leukotriene receptor antagonist medication primarily indicated for prevention and treatment of asthma symptoms, has been expanded.
The expanded insurance eligibility includes an added coverage for Singulair that has been given as an alternative treatment in patients with mild to moderat...
The expanded insurance eligibility includes an added coverage for Singulair that has been given as an alternative treatment in patients with mild to moderat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.